4 key notes on Stryker mid-year

Spinal Tech

According to Market Realist, Stryker saw an 18.5 percent year over year growth in the first quarter of 2017. The company is now looking to expand its interventional spine segment.

Here are four takeaways:


1. While the company experienced growth, the neurotechnology and spine segment contributed the least to Stryker's revenue.


2. Recently, Stryker received FDA clearance for its MultiGen 2 RF generator to help physicians perform radiofrequency ablations.


3. Stryker is confident in their expected sales for the remaining year and plans to launch interventional spine, 3D printing and titanium platforms.


4. Competing companies include Medtronic, NuVasive and Johnson & Johnson.


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers